Structure, chemistry, and pharmacokinetics of intravenous iron agents

Journal of the American Society of Nephrology

Volumn 15, Issue SUPPL. 2, 2004, Pages

  Danielson, Bo G ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Renapharma AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CHONDROITIN SULFATE IRON; COSMOFER; DEXIRON; FERRIC GLUCONATE; FERRIC HYDROXIDE; FERRIC HYDROXIDE SUCROSE; FERRUM VITIS; INFUFER; IRON; IRON 59; IRON DEXTRAN; IRON SACCHARATE; IRON SORBITEX; MALTOFER; TRANSFERRIN;

DRUG DISPOSITION; DRUG HALF LIFE; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; IRON BINDING CAPACITY; IRON CHELATION; IRON THERAPY; ISOTOPE LABELING; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; RADIOACTIVITY; RETICULOENDOTHELIAL SYSTEM; REVIEW;

EID: 9644257204     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000143814.49713.C5     Document Type: Review

References (32)

1. Heath CW, Strauss MB, Castle WB: Quantitative aspects of iron deficiency in hypochromic anemia. J Clin Invest 11: 1293-1312, 1932
2. Goetsch AT, Moore CV, Minnich V: Observations on the effect of massive doses of iron given intravenously to patients with hypochromic anemia. Blood 1: 129-142, 1946
3. Nissim JA: Intravenous administration of iron. Lancet 1: 49-51, 1947
4. Fierz F: Contribution concerning the intravenous iron therapy. Investigations with Ferrum-Hausmann. Praxis 22: 469-472, 1950
5. 59 oxide in red cell formation. J Lab Clin Med 51: 415-419, 1958
6. Martin LE, Bates CM, Beresford CR, Donaldson JD, McDonald FF, Dunlop D, Sheard P, London E, Twigg GD: The pharmacology of an iron-dextran intramuscular haematinic. Br J Pharmacol 10: 375-382, 1955
7. Nissim JA: Deposition of iron in the testes after administration of an iron dextran complex. Lancet 268: 701-702, 1955
8. Paschen HW: Efficient anaemia treatment with large intravenous iron doses. Geburtshilfe Frauenheilkunde 9: 604-616, 1949
9. Samochowiec L: [Experimental studies of enteric absorption of sodium ferric gluconate]. Clin Ter 56: 341-345, 1971
10. Wittmann G: [Treatment of iron deficiency with Ferrlecit 100]. Med Welt 24: 1141-1144, 1973
11. McCurdy PR, Rath CE, Meerkrebs GE: Parenteral iron therapy: With special reference to a new preparation for intramuscular injection. N Engl J Med 257: 1147-1153, 1957
12. Marchasin S, Wallerstein RO: The treatment of iron-deficiency anemia with intravenous iron dextran. Blood 23: 354-358, 1964
13. Becker CE, MacGregor RR, Walker KS, Jandl JH: Fatal anaphylaxis after intramuscular iron-dextran. Arch Intern Med 65: 745-748, 1966
14. Zipf RE: Fatal anaphylaxis after intravenous iron dextran. J Forensic Sci 20: 326-333, 1975
15. Wallerstein RO: Intravenous iron-dextran complex. Blood 32: 690-695, 1968
16. Hadnagy C, Markus T, Szurkos I: [Sideroblast content of the bone marrow at the end of pregnancy or 1st days of puerperium, respectively]. Zentralbl Gynakol 99: 1106-1107, 1977
17. Hadnagy C, Andreicut S, Binder P: [Geophagia sideropenica]. Folia Haematol Int Mag Klin Morphol Blutforsch 104: 648-655, 1977
18. Lawrence R: Development and comparison of iron dextran products. PDA J Pharm Sci Technol 52: 190-197, 1998
19. Geisser P, Baer M, Schaub E: Structure/histotoxicity relationship of parenteral iron preparation. Arzneim Forsch 42: 1439-1452, 1992
20. Kudasheva DS, Lai J, Ulman A, Cowman MK: Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanopartides in parenteral formulations. J Inorgan Biochem 98: online, 2004
21. Henderson PA, Hillman RS: Characteristics of iron dextran utilization in man. Blood 34: 357-375, 1969
22. Seligman PA, Dahl NV, Strobos J, Kimko HC, Schleicher RB, Jones M, Ducharme MP: Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects. Pharmacotherapy 24: 574-583, 2004
23. Danielson BG, Salmonson T, Derendorf H, Geisser P: Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneim Forsch 46: 615-621, 1996
24. Will G, Groden BM: The treatment of iron deficiency anaemia by iron-dextran infusion: A radio-isotope study. Br J Haematol 14: 61-71, 1968
25. Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, Antoni G, Langstrom B, Danielson BG: Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: A study using positron emission tomography. Br J Haematol 104: 296-302, 1999
26. Ferrlecit Product Package Insert, Corona, CA, Watson Pharmaceuticals, Inc., 2001
27. Grimes AJ, Hutt MSR: Metabolism of fe-dextran complex in human subjects. Br Med J 2: 1074-1077, 1957
28. Davidson WM, Jennison RF: The relationship between iron storage and anemia. J Clin Pathol 5: 281-285, 1952
29. Stevens AR, Coleman DH, Finch CA: Iron metabolism: Clinical evaluation of iron stores. Ann Intern Med 38: 199-205, 1953
30. Richter GW: The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals. J Exp Med 109: 197-216, 1959
31. Roe DJ, Harford AM, Zager PG, Wiltbank TB, Kirlin L, Delia Valle AM, Van Wyck DB: Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: A prospective analysis and comparison of two agents. Am J Kidney Dis 28: 855-860, 1996
32. Van Wyck DB, Anderson J, Johnson K: Labile iron in parenteral iron formulations: A quantitative and comparative study. Nephrol Dial Transplant 19: 561-563, 2004